Thanks to the alternating single-double nature of the bonds, electrons in these orbitals end up delocalized; the differences between the bonds become a bit irrelevant, and the molecule is best viewed ...

Willard announced his departure from Alkaline Trio in an Instagram post on Monday (Feb. 2). "With everything going on, going wrong in the world right now, this may seem insignificant but it's not for ...

While Bethesda has made its position very clear on Fallout game locations (it'll never stray outside of the United States) that doesn't stop people dreaming about exploring irradiated wastelands in ...

Neutral-atom arrays are a rapidly emerging platform to create quantum computers. In a foundational study led by graduate students Aaron Holman and Yuan Xu from the Will and Yu labs, respectively, the ...

HANGZHOU, China--(BUSINESS WIRE)--Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, today announced FDA approval of ...

Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, today announced FDA approval of a Phase II clinical trial ...

Imagine having your own fitness coach available at any moment, who won't charge you $100 an hour. This might now become a reality! BodyPark, a Hong Kong-based company that develops AI-powered fitness ...

An advanced nuclear startup just achieved a milestone as it races to meet an ambitious Department of Energy goal. Founded just over two years ago in July 2023, El Segundo-based Valar Atomics announced ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Atom’s lingdolinurad (ABP-671), a URAT1 inhibitor, is in late stage global clinical trials for chronic gout and ABP-745, an anti-inflammatory drug, is in multi-country Phase 2 trials for acute gout ...